B O O K - American College of Rheumatology

tuesday
B206
Joint Injections (Shoulder and Wrist Prosthetics) (218)
Speaker: Gregory C. Gardner, MD; University of Washington;
Seattle, WA
Upon completion of this session, participants should be able to:
• describe indications for upper extremity joint injection and
aspiration
• identify anatomic landmarks for injection of the shoulder and
wrist using joint prosthetics
• apply principles of joint aspiration and injection using
shoulder and wrist joint prosthetics
ARHP Concurrent Sessions
7:45 - 8:45 am
B310
Clinical Trial Essentials: Budgets, Contracts and
Regulations c/r
Moderator: Lisa M. Kastanek, RN, CCRC; Physician Research
Collaboration; Lincoln, NE
Speaker: Donah Z. Crawford, BS, MA; The Arthritis Group;
Philadelphia, PA
Session Overview:
For all members of the clinical trials team to be effective it
is necessary for each member to understand the essentials
required for successfully managing clinical trial sites and to be
aware of the contract and budgetary considerations.
Upon completion of this session, participants should be able to:
• describe the elements required to legally and ethically
conduct a clinical trial in the US
• define the basic elements of a clinical trial contract, and
budget
• explain the roles of the members of a clinical trials team
B308
Hand X-ray Review and Interpretation cP
Moderator: Aimee Wiener, ARNP C, MSN; Arthritis Autoimmune
& Asthma; Daytona Beach, FL
Speaker: Andrew J. Sulich, MD; Shores Rheumatology; St. Clair
Shores, MI
Session Overview:
The ability to read and interpret hand X-rays is fundamental
in understanding, diagnosing and managing rheumatologic
conditions. For most health care professionals in a rheumatology
practice these skills are obtained on the job. This session will
assist health care professionals in developing their knowledge
to better treat their patients.
Upon completion of this session, participants should be able to:
• describe changes commonly seen in hand osteoarthritis
including joints commonly affected, joint space narrowing,
osteophytes, and mucous cysts
• describe changes commonly seen in inflammatory arthritis
conditions including juxtaarticular osteoporosis, generalized
osteopenia, erosions, angulation, ankylosis, pencil-in-cup
deformity, lysis of terminal phalanges, fluffy periostitis, new
bone formation at enthesitis, and effusions
• identify changes seen in hemachromatosis and pseudogout
including chondrocalcinosis, squared off bone ends and hooklike
osteophytes in the 2nd and 3rd metacarpophalangeal
joints
• distinguish between erosive and classic osteoarthritis and
rheumatoid arthritis and other inflammatory conditions,
utilizing a systematic method for reading hand X-ray images
B313
Rheumatic Disease Update: Sjögren’s Syndrome c/r
Moderator: Benjamin J. Smith, PA-C; McIntosh Clinic PC;
Thomasville, GA
Steven E. Carsons, MD; Winthrop University Hospital; Mineola,
NY
Session Overview:
Sjögren’s syndrome is a common autoimmune disease seen
in rheumatology practice. This potentially debilitating disease
is often missed and/or treated inappropriately because of
confusion regarding diagnostic criteria and treatment strategies.
This timely review will address these deficiencies.
Upon completion of this session, participants should be able to:
• discuss the immunologic basis for primary Sjögren’s syndrome
• describe the classification criteria for primary Sjögren’s
syndrome
• develop a management plan for a patient with Sjögren’s
syndrome
B309
The Multidisciplinary Approach to Hereditary
Periodic Fever Syndromes P/C
Moderator: Bernadette McNally, MS, PAC; University of Utah;
Salt Lake City, UT
Speakers: Beverly K. Barham, RN MSN CCRC; NIAMS; Bethesda,
MD
Nicole D. Plass, BSN, MPA; National Institutes of Health;
Bethesda, MD
Session Overview:
Hereditary periodic fever syndromes are rare diseases caused by
genetic mutations that cause episodic inflammation. This lecture
will provide health care providers with a basic overview of the
phenotypic and genotypic presentations, health care needs, and
treatment options for patients with familial Mediterranean fever,
tumor necrosis factor-receptor associated periodic syndrome,
hyper-immunoglobulinemia D with periodic fever syndrome and
others.
Upon completion of this session, participants should be able to:
• describe the genotypic and phenotypic presentation of
familial Mediterranean fever, hyper-immunoglobulinemia D
with periodic fever syndrome, tumor necrosis factor-receptor
associated periodic syndrome and other periodic fever
syndromes
• develop a management plan for the health care needs of
families experiencing a member with a rare hereditary
periodic fever syndrome
• define treatment options and other resources for patients
with hereditary periodic fever syndromes
58
2010 Program Book